Gilman Hill Asset Management, LLC Astrazeneca PLC Transaction History
Gilman Hill Asset Management, LLC
- $594 Million
- Q3 2024
A detailed history of Gilman Hill Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gilman Hill Asset Management, LLC holds 3,703 shares of AZN stock, worth $249,582. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,703
Previous 2,578
43.64%
Holding current value
$249,582
Previous $201,000
43.28%
% of portfolio
0.05%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.24 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.83 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.51 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.48 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.29 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $209B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...